1.Short Stature Associated with Polymorphisms in Chromosome 1qh+, and 16qh+.
Ki Hwan KIM ; Sun Woo LEE ; Myung Guan KIM ; Duk Hee KIM ; Ho Seong KIM
Journal of Korean Society of Pediatric Endocrinology 2005;10(1):95-99
Chromosomal polymorphism of constitutive heterochromatin regions of chromosome 1, 9, 16, and Y is a stable evolutionary feature that is thought to cause no phenotypic alterations. The presence of definite ethinic and age-related peculiarities of chromosomal polymorphism variants was established. Some authors reported the relationship of the separate variants with the phenotypic characteristics, such as reproductive function, physiological and anthropometric indices, and oncological diseases. Nevertheless, the role of constitutive heterochromatin is still unknown. We experienced and reported short children associated with polymorphisms in chromosme 1qh+ and 16qh+.
Child
;
Chromosomes, Human, Pair 1
;
Heterochromatin
;
Humans
2.A Family of Charcot-Marie-Tooth 1A Confirmed by Molecular Genetic Analysis.
Byung Ok CHOI ; Il Nam SUNWOO ; Jin Sung LEE ; Jae Chun BAE
Journal of the Korean Neurological Association 1996;14(4):1023-1029
Recently, thanks to the development of the molecular genetics which had made us understand the nature of some genetic disorders, the concept of the classification has changed. Charcoal-Marie-Tooth disease (CMT) is the most conspicuous disease. The disease is inherited as an autosomal dominant trait. CMT is classified into two major forms: demyelinating CMT type 1 and axonal CMT type 2. CMT type 1 loci are known to map to chromosome 17 (CMT IA), chromosome 1 (CMT IB), X chromosome (CMT IX), and unknown autosome (CMT IC). And CMT type 2 loci are divided into chromosome 1 (CMT 2A) and chromosome 3 (CMT 2B). The most prevalent form is CMT IA caused by a duplication in a region of chromosome 17p11.2-12. Peripheral myelin protein-22 (PMP-22) gene In that region is known to being responsible for the disease. In Korea, although several families of CMT were reported, there is no report on the subtype of CMT type 1 confirmed by genetic analysis. We report a family of CMT IA confirmed by molecular genetic analysis using D17s122 markers.
Axons
;
Chromosomes, Human, Pair 1
;
Chromosomes, Human, Pair 17
;
Chromosomes, Human, Pair 3
;
Classification
;
Humans
;
Korea
;
Molecular Biology*
;
Myelin Sheath
;
X Chromosome
3.A Family of Charcot-Marie-Tooth 1A Confirmed by Molecular Genetic Analysis.
Byung Ok CHOI ; Il Nam SUNWOO ; Jin Sung LEE ; Jae Chun BAE
Journal of the Korean Neurological Association 1996;14(4):1023-1029
Recently, thanks to the development of the molecular genetics which had made us understand the nature of some genetic disorders, the concept of the classification has changed. Charcoal-Marie-Tooth disease (CMT) is the most conspicuous disease. The disease is inherited as an autosomal dominant trait. CMT is classified into two major forms: demyelinating CMT type 1 and axonal CMT type 2. CMT type 1 loci are known to map to chromosome 17 (CMT IA), chromosome 1 (CMT IB), X chromosome (CMT IX), and unknown autosome (CMT IC). And CMT type 2 loci are divided into chromosome 1 (CMT 2A) and chromosome 3 (CMT 2B). The most prevalent form is CMT IA caused by a duplication in a region of chromosome 17p11.2-12. Peripheral myelin protein-22 (PMP-22) gene In that region is known to being responsible for the disease. In Korea, although several families of CMT were reported, there is no report on the subtype of CMT type 1 confirmed by genetic analysis. We report a family of CMT IA confirmed by molecular genetic analysis using D17s122 markers.
Axons
;
Chromosomes, Human, Pair 1
;
Chromosomes, Human, Pair 17
;
Chromosomes, Human, Pair 3
;
Classification
;
Humans
;
Korea
;
Molecular Biology*
;
Myelin Sheath
;
X Chromosome
4.Application of real-time fluorescence quantitative PCR to rapid molecular detection of Down's syndrome.
Yi-ning HUANG ; Can LIAO ; Xin-zhi TU ; Xin YANG ; Cui-xing YI ; Li-xian LI
Chinese Journal of Medical Genetics 2005;22(6):621-623
OBJECTIVETo develop a rapid and reliable technique for the detection of Down's syndrome.
METHODSThe peripheral blood samples were collected from twenty-five Down's syndrome patients and fifty normal individuals. Four polymorphic loci on chromosomes 21, 1, 19 were amplified by real-time fluorescence quantitative PCR, and then four pairs of deltaCt values were analytically compared between the two groups.
RESULTSThe deltaCt values of Down's syndrome patients were significantly lower than those of normal individuals, and the reference ranges for clinical application were primarily established. The difference between the two groups was highly significant (P < 0.001), and the reference ranges between the two groups were not overlapped. Real-time quantitative PCR technique can effectively differentiates Down's syndrome samples from the normal fetuses; furthermore, the results were consistent with those of the karyotype analysis.
CONCLUSIONReal-time quantitative PCR is a fast and reliable method that may provide a new approach for rapid detection of Down's syndrome.
Chromosomes, Human, Pair 1 ; genetics ; Chromosomes, Human, Pair 19 ; genetics ; Chromosomes, Human, Pair 21 ; genetics ; Down Syndrome ; diagnosis ; genetics ; Humans ; Polymerase Chain Reaction ; methods ; Reproducibility of Results
5.Detection of chromosomal aberrations in multiple myeloma with fluorescence in situ hybridization.
Pengfei CAO ; Fangping CHEN ; Ye CHENG
Journal of Central South University(Medical Sciences) 2012;37(10):983-989
OBJECTIVE:
To detect of chromosomal abnormalities in multiple myeloma (MM) patients with fluorescence in situ hybridization (FISH).
METHODS:
FISH was performed in 20 MM patients using 5 specific DNA probes. The difference in chromosomal abnormalities was compared by FISH and other routine cytogenetic tests.
RESULTS:
Eighteen of the 20 patients showed chromosomal abnormalities (90%). The positive rates of t(14q32), del(13q14), dup(1q21), and p53 gene were 65% (13 in 20), 55% (11 in 20), 25% (5 in 20), and 15%(3 in 20), respectively. The abnormal rate of the conventional chromosome examination was 15% only.
CONCLUSION
FISH is more sensitive than traditional chromosomal tests and can be used as an index in prognostic evaluation for MM. Del(13q14) and t(14q32) are the most common chromosomal abnormalities in MM patients.
Chromosome Aberrations
;
Chromosomes, Human, Pair 1
;
Chromosomes, Human, Pair 13
;
Chromosomes, Human, Pair 14
;
Humans
;
In Situ Hybridization, Fluorescence
;
Multiple Myeloma
;
genetics
;
Prognosis
6.An allelotype study of primary and corresponding recurrent glioblastoma multiforme.
Jie HU ; Cheng-chuan JIANG ; Ho-Keung NG ; Jesse C S PANG ; Carol Y K TONG ; Shang-qun CHEN
Chinese Journal of Medical Genetics 2003;20(1):56-58
OBJECTIVETo investigate molecular genetic alterations associated with primary and corresponding recurrent glioblastoma multiforme(GBM) and to identify which chromosomal regions of the whole genome may be involved in the recurrence of primary GBM.
METHODSA high-resolution allelotyping study of one patient's primary GBM and corresponding recurrent GBM was performed by PCR-based loss of heterozygosity(LOH) analysis with the use of 382 fluorescent dye-labeled polymorphic microsatellite markers covering all 22 autosomes. The mean genetic distance between two flanking markers is 10 cM.
RESULTSLOH at locus D9S157 on 9p21 and at loci D10S537, D10S185, D10S192, D10S597, D10S587, D10S217 on 10q21.3-26.3 was observed in the primary GBM. As for corresponding recurrent tumor, LOH was observed not only in expanded regions on 9p21 and 10q21.3-26.3 but also on multiple other chromosomal arms, including 1q, 7p,7q, 21q, 20p, 20q, 10p, 19p, 19q.
CONCLUSIONChromosome 9p and 10q may be involved in the development of this GBM. Although histopathological diagnoses of the primary and corresponding recurrent tumor are identical, the recurrence of GBM is characterized by an increased involvement of molecular genetic abnormalities and may be accompanied by inactivation of more tumor suppressor genes.
Adult ; Alleles ; Chromosome Mapping ; methods ; Chromosomes, Human, Pair 1 ; genetics ; Chromosomes, Human, Pair 10 ; genetics ; Chromosomes, Human, Pair 19 ; genetics ; Chromosomes, Human, Pair 20 ; genetics ; Chromosomes, Human, Pair 21 ; genetics ; Chromosomes, Human, Pair 7 ; genetics ; Chromosomes, Human, Pair 9 ; genetics ; DNA ; genetics ; Female ; Glioblastoma ; genetics ; pathology ; surgery ; Humans ; Loss of Heterozygosity ; Microsatellite Repeats ; Neoplasm Recurrence, Local
7.Genentics in Rheumatoid Arthritis.
Hanyang Medical Reviews 2005;25(2):13-20
The understanding of genetic factors contributed to the susceptibility or severity of rheumatoid arthritis (RA) might give new insights into the pathways involved in disease pathogenesis and lead to the identification of novel therapeutic targets. However, a lot of published case-control association studies could not demonstrate the conclusive results due to the lack of reproducibility, small sample size, poor study design, incorrect assumption, and ethnic diversity. Recently, several genome-wide scan using affected sibling pairs and following candidate gene approaches have been performed to unravel the complex association of rheumatoid arthritis with the human leukocyte antigen (HLA) gene region, non-HLA major histocompatibility region within chromosome 6, and the other chromosomes such as chromosome 1. This review summarizes the importance of genetic studies in RA, and the variable methods of genetic studies and their results.
Arthritis, Rheumatoid*
;
Case-Control Studies
;
Chromosomes, Human, Pair 1
;
Chromosomes, Human, Pair 6
;
Genetics
;
Histocompatibility
;
Humans
;
Leukocytes
;
Sample Size
;
Siblings
8.Chromosomal cryptic insertion of the terminal region and its formative mechanism determined by fluorescence in situ hybridization.
Chinese Medical Journal 2002;115(7):1039-1042
OBJECTIVETo determine the karyotype of a cryptic structural abnormality and explore the mechanism of apparent chromosomal terminal deletion.
METHODSFluorescence in situ hybridization(FISH) with a whole chromosome 7 painting probe and a 7q subterminal probe (7q36-->qter), prepared by chromosome microdissection technique, was used to analyze a case with a history of spontaneous abortion and 7q terminal deletion detected by conventional G-banding technique.
RESULTSThe case was a maternal cryptic insertional translocation between chromosome region 1p32 and 7q32-->q35. The region of chromosome 7q36-->qter was not inserted in to chromosome 1, and the abnormal chromosome 7 was not a terminal deletion but an interstitial deletion.
CONCLUSIONSChromosome insertion of the terminal region retains its telomere, which is consistent with the concept of a three-break rearrangement. Interstitial deletion may be regarded as another mechanism for terminal deletion in the chromosome banding level. Combined with chromosome microdissection, FISH technique could be a powerful diagnostic tool for detecting chromosome structural abnormalities.
Adult ; Chromosome Aberrations ; Chromosomes, Human, Pair 1 ; Chromosomes, Human, Pair 7 ; Female ; Humans ; In Situ Hybridization, Fluorescence ; methods
9.Adverse effects of double-hit combining ISS-Ⅲ stage and 1q gain or del (17p) on prognosis of patients with newly diagnosed multiple myeloma.
Xue Lian LIU ; Yan Ping YANG ; Jing BAI ; Ting Ting YUE ; Pei Yu YANG ; Ye ZHANG ; Hong Qiong FAN ; Wei LI ; Feng Yan JIN
Chinese Journal of Hematology 2019;40(11):912-917
Objective: To evaluate the prognostic significance of combining ISS-Ⅲ and high risk cytogenetic abnormalities [HRCAs, including 1q gain/amplification and del (17p) ] in patients with newly-diagnosed multiple myeloma (NDMM) . Methods: The clinical characteristics and relevant variables were retrospectively analyzed in a total of 270 NDMM patients diagnosed between November 2009 and May 2018. ISS-Ⅲ stage and HRCAs [detected by FISH, including 1q gain/amplification and del (17p) ] were defined as risk factors (hit) . Based to the number of hit per case, these patients were divided into four groups carrying 0 to 3 risk factors, respectively. Progress-free survival (PFS) and overall survival (OS) were then analyzed using the Kaplan-Meier estimator. Results: Patients who carried single hit (n=120, 44.4%) had shorter median PFS (23.0 vs 28.9 months; P>0.05) and OS (42.3 vs 53.7 months; P>0.05) than those with no risk factors (n=66, 24.4%) . Of note, the outcome of patients who had two or more risk factors (double/triple, n=84, 31.1%) was much worse than those with either no or one risk factor, indicated by significantly reduced median PFS (14.5 months; HR=1.584, 95%CI 1.082-2.319; P=0.003 for double/triple vs single hit) and OS (18.4 months, HR=2.299, 95%CI 1.485-3.560; P<0.001 for double/triple vs single hit) . Strikingly, patients who had three risk factor (triple hit, n=5, 1.9%) displayed the poorest survival with extraordinarily shorter PFS (0.9-15.1 months) and OS (0.9-18.9 months) compared to those carrying two risk factors (double hit) . Analogous results were obtained when different combinations of ISS stages and HRCAs were analyzed. Conclusion: These results suggest a potential but rather important role of combining multiple (e.g. double or triple) adverse factors determined via the routine ISS staging and FISH detection of cytogenetic abnormalities in risk stratification and prognostic prediction, which might be helpful to identify high risk patients more precisely at diagnosis. It also raised a possibility that a small group of ISS-Ⅲ patients carrying both 1q gain/amplification and del (17p) might represent an "extremely-high risk" subset of MM.
Chromosome Aberrations
;
Chromosomes, Human, Pair 1
;
Chromosomes, Human, Pair 17
;
Humans
;
Multiple Myeloma
;
Neoplasm Staging
;
Prognosis
;
Retrospective Studies
;
Survival Analysis